{"id":"390087","title":"Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity","author":null,"feed":"PRTGAM","feedName":"Newswire.ca","published":"Tue Feb 24, 8:35AM CST","image":"N/A","content":"

Late-Stage Pipeline Advancements and Novel Therapies Position Sector for Accelerated Growth and Major Value Catalysts

Market News Updates News Commentary

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

","related":[{"id":"1527731","title":"Kepler Capital Sticks to Their Hold Rating for Redcare Pharmacy (0RJT)","slug":"kepler-capital-sticks-to-their-hold-rating-for-redcare-pharmacy-0rjt","feedName":"Tipranks","published":"13 minutes ago","categories":[]},{"id":"1527729","title":"Kepler Capital Sticks to Their Hold Rating for Tubacex (0KD1)","slug":"kepler-capital-sticks-to-their-hold-rating-for-tubacex-0kd1","feedName":"Tipranks","published":"13 minutes ago","categories":[]},{"id":"1527727","title":"Kepler Capital Reaffirms Their Buy Rating on Viscofan (0MKW)","slug":"kepler-capital-reaffirms-their-buy-rating-on-viscofan-0mkw","feedName":"Tipranks","published":"13 minutes ago","categories":[]},{"id":"1527725","title":"Kepler Capital Reaffirms Their Hold Rating on Fnac Darty SA (0QSH)","slug":"kepler-capital-reaffirms-their-hold-rating-on-fnac-darty-sa-0qsh","feedName":"Tipranks","published":"13 minutes ago","categories":[]},{"id":"1527723","title":"Kepler Capital Keeps Their Buy Rating on Lectra SA (0IVJ)","slug":"kepler-capital-keeps-their-buy-rating-on-lectra-sa-0ivj","feedName":"Tipranks","published":"13 minutes ago","categories":[]},{"id":"1527721","title":"Kepler Capital Remains a Buy on Tomra Systems ASA (0KV7)","slug":"kepler-capital-remains-a-buy-on-tomra-systems-asa-0kv7","feedName":"Tipranks","published":"13 minutes ago","categories":[]},{"id":"1527719","title":"Kepler Capital Remains a Buy on Xior Student Housing N.V. (0RD8)","slug":"kepler-capital-remains-a-buy-on-xior-student-housing-n-v-0rd8","feedName":"Tipranks","published":"13 minutes ago","categories":[]},{"id":"1527717","title":"Kepler Capital Sticks to Their Buy Rating for INFICON Holding AG (IFCN)","slug":"kepler-capital-sticks-to-their-buy-rating-for-inficon-holding-ag-ifcn","feedName":"Tipranks","published":"13 minutes ago","categories":[]},{"id":"1527715","title":"Kepler Capital Sticks to Their Buy Rating for Duni AB (2DU)","slug":"kepler-capital-sticks-to-their-buy-rating-for-duni-ab-2du","feedName":"Tipranks","published":"13 minutes ago","categories":[]}],"sourceId":"newswireca-2026-2-24-next-generation-psychiatric-therapies-target-massive-40b-market-opportunity","media":"text","thumbnail":"N/A","canonicalUrl":"https://www.newswire.ca/news-releases/next-generation-psychiatric-therapies-target-massive-40b-market-opportunity-866593376.html","feedUrl":null,"slug":"next-generation-psychiatric-therapies-target-massive-40b-market-opportunity"}

Latest in

More

Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity